Grifols bags €100M for Alzheimer’s R&D; Ipsen inks $137M cancer deal; Oryzon raises €17M

Nick Paul Taylor

In this week's EuroBiotech Report, Catalan biotech secured a €100 million ($ 110 million) loan from the European Investment Bank's €315 billion fund. The money will support a ratcheting up of R&D into Alzheimer's disease and other indications. And more.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS